Hey @kevinxu, I see you have been getting a lot of flack lately. It’s all over my newsfeed. You got the attention that you wanted.
But just a stupid idea of mine to you.
Why don’t you refund people the $200 for the month on a play that doesn’t work out?
It’s very similar to how sport handicappers sell their picks. They only keep the payment if the play ends up right.
I think this can help boost your reputation that is slightly damaged recently.
With X Money it’s instantaneous (assuming your subs have signed up).
Just an idea again.
Rates Cap Tech Hard
30Y yields smash 5.25%, slamming a hard ceiling on high-multiple tech. Sept Fed hike odds ~36%. Duration pain incoming.
#Rates#Tech#Fed
US Stocks Rebound on Big Tech Earnings
Nasdaq +2.5%, S&P +1.5%, Dow +1.2% as Microsoft crushed earnings on Azure momentum. Reversal from yesterday’s Fed-induced selloff amid sticky inflation and rising yields. AMZN & AAPL up next. Vol still elevated.
$TMDE
Expected Upside: 16-20%
TMD Energy Ltd. is a holding company primarily engaged in the supply and sale of marine fuel gas and oil. The company provides marine bunkering services, including ship-to-ship (STS) fuel transfer. Headquartered in Kuala Lumpur, Malaysia.
$NVO probably had its fastest and most successful launch ever with oral-Wegovy.
Given that Eli Lilly's Orforglipron is also delayed, $NVO has a real shot at establishing dominance in the oral weight loss drug market.
$LLY won't be able to catch up so fast this time as oral-Wegovy is a better product than Orforglipron.
$NVO estimates will need to be revised upward, which will bump up the stock price substantially.
Long $NVO, next stop $80.
$ATOS
Target Price: $0.90
FDA grants (Z)-Endoxifen DMD orphan drug designation, along with tax breaks and market exclusivity; EVAGELINE breast cancer trial data to be released in the first half of 2026.
$EQ
Target Price: $1.40.
The company has completed a $50 million funding round, with $30 million earmarked to support the Phase 1 study of EQ504, scheduled to launch in 2026. Further developments may be announced at the 2026 conference.
$BW
Target Price: $9.40
BW 2026 Outlook: $1.5B full contract release (Q1) & over $5B AI data center pipeline to drive growth. Targets $70-85M core EBITDA, supported by recent debt reduction and new project wins, positioning for strong share price performance